Minimizing Type 2 Errors in an Experiment-Rich Regime via Optimal Resource Allocation
实验密集环境下通过最优资源配置降低第二类错误AI 解读 ↓
本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。
本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。
AI 根据所提供的论文材料归类:摘要以随机实验中的治疗效应检出为目标,讨论实验资源配置及统计功效,最直接对应因果推断方向。
实验密集环境下通过最优资源配置降低第二类错误AI 解读 ↓
正在核对关联版本…
正在核对对应版本的资源…
Randomized experiments (often known as "A/B tests") are widely used to evaluate product and service innovations. We study how to allocate limited experimentation resources across M concurrent experiments in an experiment-rich regime. Existing work on allocation has predominantly focused on minimizing the worst-case mean squared error (MSE) of estimated treatment effects, which favors experiments with larger (and typically unknown) outcome variance. While appropriate for controlling estimation accuracy, this objective does not directly capture a common managerial priority in screening stages: detecting practically meaningful treatment effects with high probability. Motivated by this, we consider the objective of minimizing the worst-case Type II error across all experiments. When the standard deviations are known, we characterize the power-optimal allocation and show that MSE-based allocations can be highly inefficient for detection, even though the two objectives align asymptotically. When the standard deviations are unknown and must be learned from pilot data, we show that a naive plug-in approach, treating pilot standard deviations as truth, can suffer substantial power loss. We propose inflating pilot estimates via correction factors and develop three optimization-based frameworks for selecting them, each reflecting a different risk criterion with distinct managerial implications. Although the resulting stochastic programs are computationally challenging at scale, we derive tractable surrogate reformulations inspired by robust optimization and establish favorable theoretical properties. We further propose Surrogate-S, a fully data-dependent and implementable procedure that computes correction factors using only pilot variance estimates and achieves near-oracle performance in numerical experiments.
Two frequent approaches for identifying structural VARs are external instruments, which carry economic content but are often weak, and non-Gaussianity of the shocks, which provides statistical identification but carries no economic meaning. We combine the two strategies in a single generalized method of moments framework. This hybrid approach point-identifies the target shocks while also identifying the non-target shocks up to sign and ordering. Under suitable rank…
The conditional average treatment effect (CATE) is frequently estimated in clinical studies to refute a homogeneous treatment effect hypothesis. Under this regime, all patients making up the population experience identical benefit from a given treatment relative to a comparator. Uncovering heterogeneous treatment effects through inference about the CATE, however, requires that covariates truly modifying the treatment effect be reliably collected at baseline. CATE-based…
内生性检验:一种基于矩的贝叶斯方法
A standard assumption in the Bayesian estimation of linear regression models is that the regressors are exogenous in the sense that they are uncorrelated with the model error term. In practice, however, this assumption can be invalid. In this article, using the exponentially tilted empirical likelihood (ETEL) framework, we develop a Bayes factor test for endogeneity that compares a base model that is correctly specified under exogeneity but misspecified under endogeneity…
We study difference-in-differences designs in which all units are initially untreated and later receive heterogeneous, strictly positive treatment doses. When quasi-untreated units receive doses close to zero, a difference-in-difference estimand using those units as the control group identifies a weighted average treatment effect per unit of treatment, under a parallel-trends assumption. We develop a nonparametric estimator and bias-corrected confidence intervals for this…
伪面板事件研究:可信应用的计量经济学基础
Event studies with panel data are widely used to estimate treatment effects. With repeated cross-sections, future treatment dates are unobserved for untreated individuals. Pseudo-panel event studies impute pre-treatment outcomes of the treated using matched untreated individuals. This paper establishes identification in such designs and characterizes bias when identification conditions fail. I show that the pseudo-panel regression is equivalent to weighted least squares with…
自适应实验中策略改进价值的推断
In this paper, we develop an asymptotically normal estimator for the value of policy improvement (VPI) under adaptively collected data. This value, which is defined as the gap between the value of the best treatment policy in a class and that of a baseline policy, gauges whether or not it is worth deploying a personalized treatment policy. Building an estimator for the VPI is naturally more difficult than estimating the value of a fixed policy. This is because, in addition…